0001756702-22-000002.txt : 20220502 0001756702-22-000002.hdr.sgml : 20220502 20220502134415 ACCESSION NUMBER: 0001756702-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220502 DATE AS OF CHANGE: 20220502 EFFECTIVENESS DATE: 20220502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Castle Creek Biosciences, Inc. CENTRAL INDEX KEY: 0001756702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831984773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-444058 FILM NUMBER: 22880903 BUSINESS ADDRESS: STREET 1: 6 CENTURY DRIVE, 2ND FLOOR CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 847-715-0606 MAIL ADDRESS: STREET 1: 6 CENTURY DRIVE, 2ND FLOOR CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Castle Creek Pharmaceutical Holdings, Inc. DATE OF NAME CHANGE: 20181023 D 1 primary_doc.xml X0708 D LIVE 0001756702 Castle Creek Biosciences, Inc. 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 (484) 713-6190 DELAWARE Castle Creek Pharmaceutical Holdings, Inc. Corporation true 2018 Jeffrey S. Aronin 330 N. Wabash Suite 3500 Chicago IL ILLINOIS 60611 Director Matthew J. Gantz 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Executive Officer Director Antonio J. Gracias 330 N. Wabash Suite 3500 Chicago IL ILLINOIS 60611 Director W. Bradford Middlekauff 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Executive Officer Mary Spellman 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Executive Officer Patrick J. Morris 330 N. Wabash Suite 3500 Chicago IL ILLINOIS 60611 Director Mark Graf 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Director Biotechnology Decline to Disclose 06b false 2022-04-19 false true false 0 Paragon Health Capital, LLC 300729 None None 330 N. Wabash Suite 3500 Chicago IL ILLINOIS 60611 CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS MA MASSACHUSETTS MN MINNESOTA NY NEW YORK PA PENNSYLVANIA false 112782892 112782892 0 Offering includes the value of exercised Convertible Securities to Preferred Stock. false 54 1694611 0 0 false Castle Creek Biosciences, Inc. /s/ W. Bradford Middlekauff W. Bradford Middlekauff Secretary 2022-05-02